These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 7697466)
1. Enhanced resistance against lethal disseminated Candida albicans infection in mice treated with polar glycopeptidolipids from Mycobacterium chelonae (pGPL-Mc). Lagrange PH; Fourgeaud M; Neway T; Pilet C C R Acad Sci III; 1994 Dec; 317(12):1107-13. PubMed ID: 7697466 [TBL] [Abstract][Full Text] [Related]
2. Mycobacterial polar glycopeptidolipids enhance resistance to experimental murine candidiasis. Lagrange PH; Fourgeaud M; Neway T; Pilet C C R Acad Sci III; 1995 Mar; 318(3):359-65. PubMed ID: 7788504 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant activity of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on the immunogenic and protective effects of an inactivated influenza vaccine. Gjata B; Hannoun C; Boulouis HJ; Neway T; Pilet C C R Acad Sci III; 1994 Mar; 317(3):257-63. PubMed ID: 7994612 [TBL] [Abstract][Full Text] [Related]
4. [Activity of polar glycopeptidolipids from Mycobacterium chelonae in the reversal of chemically induced leukopenia in mice]. Neway T; Boulouis HJ; Thibault D; Pilet C C R Acad Sci III; 1992; 315(1):13-9. PubMed ID: 1422916 [TBL] [Abstract][Full Text] [Related]
5. Effects of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on granulomacrophage progenitors. Vincent-Naulleau S; Neway T; Thibault D; Barrat F; Boulouis HJ; Pilet C Res Immunol; 1995; 146(6):363-71. PubMed ID: 8719660 [TBL] [Abstract][Full Text] [Related]
6. Effects of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on haematopoietic regeneration and resistance to infection of sublethally irradiated mice. Neway T; Mazetier-Chicha P; Devauchelle P; Thibault D; Boulouis HJ; Barrat F; Vincent-Naulleau S; Pilet C Res Immunol; 1996 Jan; 147(1):39-48. PubMed ID: 8739327 [TBL] [Abstract][Full Text] [Related]
7. Stimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae on murine haematopoietic stem cells and megakaryocyte progenitors. Vincent-Naulleau S; Thibault D; Neway T; Pilet C Res Immunol; 1997 Feb; 148(2):127-36. PubMed ID: 9226767 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary defence mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans. Lal S; Mitsuyama M; Miyata M; Ogata N; Amako K; Nomoto K J Clin Lab Immunol; 1986 Mar; 19(3):127-33. PubMed ID: 3519975 [TBL] [Abstract][Full Text] [Related]
9. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice. Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575 [TBL] [Abstract][Full Text] [Related]
10. Effect of polar glycopeptidolipids from Mycobacterium chelonae (GPLp-Mc) on phagocytosis and superoxide anion production of macrophages from mice. Influence of physical activity. García García JJ; Barriga C; Rodríguez AB; Ortega E Mol Cell Biochem; 1998 Jun; 183(1-2):159-63. PubMed ID: 9655191 [TBL] [Abstract][Full Text] [Related]
11. Immunostimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae for inactivated rabies vaccine. de Souza Matos DC; Marcovistz R; Neway T; Vieira da Silva AM; Alves EN; Pilet C Vaccine; 2000 Apr; 18(20):2125-31. PubMed ID: 10715527 [TBL] [Abstract][Full Text] [Related]
12. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052 [TBL] [Abstract][Full Text] [Related]
13. Preliminary evaluation of immunoadjuvant activity of an orally administered glucan extracted from Candida albicans. Nicoletti A; Nicoletti G; Ferraro G; Palmieri G; Mattaboni P; Germogli R Arzneimittelforschung; 1992 Oct; 42(10):1246-50. PubMed ID: 1472146 [TBL] [Abstract][Full Text] [Related]
14. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice. Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691 [TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans. Ito S; Pedras-Vasconcelos J; Klinman DM Infect Immun; 2005 Sep; 73(9):6154-6. PubMed ID: 16113339 [TBL] [Abstract][Full Text] [Related]
16. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice. Dimitrova P; Ivanovska N Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122 [TBL] [Abstract][Full Text] [Related]
17. Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection. Hurtrel B; Lagrange PH; Michel JC Ann Immunol (Paris); 1980; 131C(1):105-18. PubMed ID: 6249181 [TBL] [Abstract][Full Text] [Related]
18. Low dose of Concanavalin-A enhances innate immune response and prevents liver injury in mice infected with Candida albicans. Conchon-Costa I; Loyola W; Gaziri LC; Custódio LA; Felipe I FEMS Immunol Med Microbiol; 2007 Apr; 49(3):330-6. PubMed ID: 17284281 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of oral administration of a traditional medicine, Juzen-Taiho-To, and its components on lethal Candida albicans infection in immunosuppressed mice. Abe S; Tansho S; Ishibashi H; Inagaki N; Komatsu Y; Yamaguchi H Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):421-31. PubMed ID: 9736446 [TBL] [Abstract][Full Text] [Related]
20. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]